Antihypertensive Medication Adherence Stroke and Death
- Kate Lapane PhD
- … show all 1 hide
To the Editor:—I read with great interest the recent articles by Fischer et al. 1 and Bailey et al. 2 which describe the extent of primary non-adherence and document the adverse impact of non-adherence among those with hypertension. Bailey et al. 2 conclude that by increasing adherence by one pill per week for a once-a-day regimen the hazard of stroke could be reduced by 8–9% and death by 7%. The public health impact of non-adherence should not be minimized.
I agree with Fischer et al. 1 that e-prescribing could improve adherence. In 2006, we interviewed 276 clinicians and staff in 64 practices using one of six e-prescribing products. When asked about e-prescribing software with the capability of alerting the physician when the patient has not picked up a prescription, 47% reported that would be very useful. Yet, these data run counter to the real experience of beta testing e-prescribing in 2003 in Rhode Island. The original plan was to alert the prescriber when prescriptions were not p
- Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010 Feb 4. [Epub ahead of print].
- Bailey JE, Wan JY, Tang J, Ghani MA, Cushman WC. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. 2010 Feb 18. [Epub ahead of print].
- Lapane KL, Dubé CE, Schneider KL, Quilliam BJ. Misperceptions of patients vs. providers regarding medication-related communication issues. Am J Manag Care. 2007;13(11):613–8.
- Antihypertensive Medication Adherence Stroke and Death
Journal of General Internal Medicine
Volume 25, Issue 8 , p 762
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Kate Lapane PhD (1)
- Author Affiliations
- 1. Virginia Commonwealth University, 830 East Main Road, Richmond, VA, 23298, USA